`571-272-7822
`
`
` Paper No. 22
` Entered June 1, 2021
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`
`Regeneron Pharmaceuticals, Inc.,
`Petitioner
`
`v.
`Novartis Pharma AG,
`Novartis Technology LLC,
`Novartis Pharmaceuticals Corporation,
`PATENT Owner
`_______________
`
`IPR2020-01317
`Patent 9,220,631 B2
`
`Mailed: June 1, 2021
`NOTICE OF REFUND
`
`
`
`Petitioner’s request for a refund of certain post-institution fees paid on
`July 16, 2020, in the above proceeding is hereby granted. The amount of
`$21,600.00 has been refunded to Petitioner’s deposit account.
`The parties are reminded that unless otherwise permitted by 37 C.F.R.
`§ 42.6(b)(2), all filings in this proceeding must be made electronically in the
`Patent Trial and Appeal Board End to End (PTAB E2E), accessible from the
`Board Web site at http://www.uspto.gov/PTAB.
`
`
`
`
`
`
`IPR2020-01317
`Patent 9,220,631 B2
`
`
`If there are any questions pertaining to this notice, please contact the
`Patent Trial and Appeal Board at 571-272-7822.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`
`
`
`IPR2020-01317
`Patent 9,220,631 B2
`
`
`PETITIONER:
`
`Elizabeth Weiswasser
`elizabeth.weiswasser@weil.com
`Anish Desai
`anish.desai@weil.com
`Brian Ferguson
`brian.ferguson@gweil.com
`Christopher Pepe
`christopher.pepe@weil.com
`
`
`PATENT OWNER:
`
`Elizabeth J. Holland
`eholland@goodwinlaw.com
`William G. James
`wjames@goodwinlaw.com
`Linnea Cipriano
`lcipriano@goodwinlaw.com
`Joshua Weinger
`jweinger@goodwinlaw.com
`
`
`
`3
`
`